# Chemotherapy in Treating Patients With Sarcoma of the Uterus

> **NCT00005643** · PHASE2 · COMPLETED · sponsor: **Gynecologic Oncology Group**

## Conditions studied

- Endometrial Cancer
- Sarcoma

## Interventions

- **DRUG:** pegylated liposomal doxorubicin hydrochloride

## Key facts

- **NCT ID:** NCT00005643
- **Lead sponsor:** Gynecologic Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-05
- **Primary completion:** 2005-03
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-06-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005643, "Chemotherapy in Treating Patients With Sarcoma of the Uterus". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00005643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*